Applications, hearings, determinations, etc.: Dupont Pharmaceuticals,

Text

---

Federal Register: October 11, 2001 (Volume 66, Number 197)NoticesPage 51969From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr11oc01-110

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances, Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 25, 2001, Dupont Pharmaceuticals, 1000 Stewart Avenue, Garden City, New York 11530, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug

Schedule

Oxycodone (9143)........................... II Hydrocodone (9193)......................... II Oxymorphone (9652)......................... II

The firm plans to manufacture the listed controlled substances to make finished products.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections tot he issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than December 10, 2001.

Dated: October 2, 2001. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

FR Doc. 01-25443Filed10-10-01; 8:45 amBILLING CODE 4410-09-M

If you are already a vLex customer, access here

---